Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Quality Improvement | 12 | 2016 | 246 | 2.320 |
Why?
|
| Delivery of Health Care | 7 | 2018 | 243 | 2.170 |
Why?
|
| Quality Assurance, Health Care | 5 | 2013 | 189 | 1.540 |
Why?
|
| Health Care Reform | 3 | 2018 | 59 | 1.150 |
Why?
|
| Organizational Innovation | 5 | 2018 | 62 | 0.860 |
Why?
|
| Hospitals | 4 | 2016 | 195 | 0.860 |
Why?
|
| Cross Infection | 3 | 2009 | 78 | 0.860 |
Why?
|
| Staphylococcal Infections | 3 | 2009 | 83 | 0.790 |
Why?
|
| Data Interpretation, Statistical | 3 | 2021 | 148 | 0.780 |
Why?
|
| Philosophy | 2 | 2013 | 11 | 0.760 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 30 | 0.720 |
Why?
|
| Data Collection | 2 | 2013 | 298 | 0.720 |
Why?
|
| Audiovisual Aids | 1 | 2021 | 8 | 0.710 |
Why?
|
| Epidemiologic Methods | 1 | 2021 | 55 | 0.700 |
Why?
|
| Models, Organizational | 3 | 2018 | 71 | 0.690 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2009 | 42 | 0.600 |
Why?
|
| Population Surveillance | 2 | 2009 | 144 | 0.560 |
Why?
|
| Hospitals, Community | 5 | 2011 | 36 | 0.560 |
Why?
|
| Infection Control | 2 | 2009 | 62 | 0.520 |
Why?
|
| Models, Theoretical | 2 | 2015 | 202 | 0.520 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 198 | 0.500 |
Why?
|
| Patient Safety | 2 | 2014 | 139 | 0.460 |
Why?
|
| Health Care Costs | 1 | 2015 | 113 | 0.450 |
Why?
|
| United States | 11 | 2018 | 4886 | 0.450 |
Why?
|
| Research Design | 2 | 2021 | 419 | 0.440 |
Why?
|
| Quality of Health Care | 3 | 2013 | 347 | 0.440 |
Why?
|
| Information Dissemination | 2 | 2016 | 84 | 0.410 |
Why?
|
| Science | 1 | 2013 | 31 | 0.400 |
Why?
|
| Diffusion of Innovation | 2 | 2011 | 52 | 0.390 |
Why?
|
| Safety Management | 1 | 2013 | 109 | 0.390 |
Why?
|
| Judgment | 1 | 2012 | 23 | 0.380 |
Why?
|
| Humans | 25 | 2021 | 40217 | 0.380 |
Why?
|
| Medical Errors | 1 | 2013 | 146 | 0.370 |
Why?
|
| Physics | 1 | 2011 | 7 | 0.360 |
Why?
|
| Health Resources | 1 | 2011 | 49 | 0.350 |
Why?
|
| Health Services Misuse | 1 | 2011 | 15 | 0.350 |
Why?
|
| Economics, Hospital | 1 | 2010 | 8 | 0.340 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2011 | 552 | 0.330 |
Why?
|
| Disease Notification | 1 | 2009 | 5 | 0.310 |
Why?
|
| Hospitalization | 1 | 2013 | 729 | 0.300 |
Why?
|
| Health Personnel | 1 | 2011 | 236 | 0.300 |
Why?
|
| Learning | 1 | 2009 | 124 | 0.280 |
Why?
|
| Organizational Case Studies | 2 | 2018 | 33 | 0.280 |
Why?
|
| Cooperative Behavior | 1 | 2009 | 158 | 0.280 |
Why?
|
| Fluoroquinolones | 1 | 2007 | 12 | 0.270 |
Why?
|
| Psychometrics | 1 | 2008 | 272 | 0.270 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2005 | 3 | 0.250 |
Why?
|
| Equipment Contamination | 1 | 2005 | 26 | 0.240 |
Why?
|
| Vancomycin Resistance | 1 | 2005 | 3 | 0.240 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 130 | 0.220 |
Why?
|
| Bacteria | 1 | 2005 | 258 | 0.200 |
Why?
|
| Escherichia coli | 1 | 2007 | 622 | 0.200 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 463 | 0.180 |
Why?
|
| Leadership | 2 | 2014 | 142 | 0.170 |
Why?
|
| Intensive Care Units | 1 | 2021 | 215 | 0.160 |
Why?
|
| Computer Simulation | 1 | 2021 | 345 | 0.150 |
Why?
|
| Food Assistance | 1 | 2018 | 4 | 0.140 |
Why?
|
| Pandemics | 1 | 2021 | 331 | 0.140 |
Why?
|
| Cost Control | 1 | 2015 | 18 | 0.120 |
Why?
|
| Qualitative Research | 1 | 2018 | 421 | 0.110 |
Why?
|
| Total Quality Management | 2 | 2013 | 45 | 0.110 |
Why?
|
| Organizational Culture | 2 | 2011 | 79 | 0.110 |
Why?
|
| Efficiency, Organizational | 2 | 2011 | 64 | 0.110 |
Why?
|
| Hospital Mortality | 1 | 2016 | 459 | 0.110 |
Why?
|
| Surveys and Questionnaires | 2 | 2011 | 1792 | 0.110 |
Why?
|
| Medical Audit | 1 | 2014 | 51 | 0.110 |
Why?
|
| Bibliometrics | 1 | 2013 | 23 | 0.110 |
Why?
|
| Interprofessional Relations | 1 | 2014 | 96 | 0.100 |
Why?
|
| Clinical Coding | 1 | 2013 | 28 | 0.100 |
Why?
|
| Probability | 1 | 2013 | 102 | 0.100 |
Why?
|
| Physician's Role | 1 | 2014 | 95 | 0.100 |
Why?
|
| Sampling Studies | 1 | 2012 | 54 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2013 | 169 | 0.100 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 151 | 0.100 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 108 | 0.100 |
Why?
|
| Education, Continuing | 1 | 2011 | 17 | 0.090 |
Why?
|
| Social Networking | 1 | 2011 | 18 | 0.090 |
Why?
|
| Delphi Technique | 1 | 2011 | 59 | 0.090 |
Why?
|
| Global Health | 1 | 2011 | 118 | 0.090 |
Why?
|
| Sample Size | 1 | 2010 | 40 | 0.080 |
Why?
|
| Life Expectancy | 1 | 2010 | 22 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 167 | 0.080 |
Why?
|
| Health Status Indicators | 1 | 2010 | 60 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 289 | 0.080 |
Why?
|
| Creatine Kinase | 1 | 2009 | 31 | 0.080 |
Why?
|
| Acetamides | 1 | 2009 | 8 | 0.080 |
Why?
|
| Oxazolidinones | 1 | 2009 | 12 | 0.080 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2009 | 10 | 0.080 |
Why?
|
| Poisson Distribution | 1 | 2009 | 36 | 0.080 |
Why?
|
| Observer Variation | 1 | 2008 | 107 | 0.070 |
Why?
|
| Program Development | 1 | 2009 | 157 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 287 | 0.070 |
Why?
|
| Health Status | 1 | 2010 | 297 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2009 | 350 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2010 | 463 | 0.070 |
Why?
|
| Anti-Infective Agents | 1 | 2009 | 105 | 0.070 |
Why?
|
| Primary Health Care | 1 | 2011 | 458 | 0.070 |
Why?
|
| Logistic Models | 1 | 2009 | 813 | 0.060 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2007 | 72 | 0.060 |
Why?
|
| Health Promotion | 1 | 2010 | 415 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 1055 | 0.060 |
Why?
|
| Laboratories, Hospital | 1 | 2005 | 5 | 0.060 |
Why?
|
| Penicillin Resistance | 1 | 2005 | 9 | 0.060 |
Why?
|
| Vancomycin | 1 | 2005 | 21 | 0.060 |
Why?
|
| Renal Dialysis | 1 | 2005 | 124 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2009 | 3138 | 0.040 |
Why?
|
| Adult | 2 | 2014 | 10255 | 0.030 |
Why?
|
| Male | 3 | 2014 | 18271 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 238 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 282 | 0.020 |
Why?
|
| Decision Making, Organizational | 1 | 2011 | 23 | 0.020 |
Why?
|
| Organizational Objectives | 1 | 2011 | 46 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2010 | 40 | 0.020 |
Why?
|
| Medical Record Linkage | 1 | 2010 | 19 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 450 | 0.020 |
Why?
|
| Linezolid | 1 | 2009 | 4 | 0.020 |
Why?
|
| Mortality | 1 | 2010 | 88 | 0.020 |
Why?
|
| Hypolipidemic Agents | 1 | 2009 | 20 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2010 | 94 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2010 | 213 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 562 | 0.020 |
Why?
|
| Health Behavior | 1 | 2010 | 395 | 0.020 |
Why?
|
| Massachusetts | 1 | 2011 | 1701 | 0.020 |
Why?
|
| Middle Aged | 1 | 2014 | 10090 | 0.010 |
Why?
|
| Aged | 1 | 2009 | 8182 | 0.010 |
Why?
|
| Female | 1 | 2014 | 20392 | 0.010 |
Why?
|